Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1501 to 1525 of about 5897

Previous 25

Website Changes

04/06/2017

Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

04/06/2017

Tocagen wins "Most Successful Early Phase Trial" and "Excellence in Rare Disease Drug Development" awards!

04/06/2017

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

04/05/2017

Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma

04/05/2017

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

04/03/2017

"Sci-fi" cancer therapy fights brain tumors, study finds

03/29/2017

MGH/Dana Farber Initiate Expansion of ONC201 Glioblastoma Trial

03/21/2017

VBI Vaccines Building On Duke University Research for New Cancer Therapy

03/20/2017

Is it time for "Conditional Approvals"?

03/17/2017

Antibody treats pediatric brain tumors safely and effectively in mice

03/17/2017

Medicenna BioPharma Announces Strategic Collaboration with MD Anderson Cancer Center to Advance Next Generation Empowered Cytokines™

03/17/2017

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.

03/10/2017

Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.

03/10/2017

4th ANNUAL HOOPS FOR HANNAH FUNDRAISER FOR BRAIN TUMOR RESEARCH

03/10/2017

Ependymoma Awareness Day.

03/10/2017

Clinical Trial Announcement Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Glioblastoma at First Recurrence or Progression

03/10/2017

Trump Chooses Dr. Scott Gottlieb To Head Food And Drug Administration

03/09/2017

Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization

03/08/2017

Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.

03/08/2017

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children set to open soon

03/07/2017

Help us better Understand Patient Experiences with Glioblastoma Multiforme

02/26/2017

Renowned Neuro-oncologist Joining Northwestern

02/23/2017

Tocagen Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Toca 511 & Toca FC in Recurrent High Grade Glioma

02/22/2017

UPDATED: Agenus’ lead cancer vaccine flops, investigators read last rites over glioblastoma PhII

02/21/2017

Help us better Understand Patient Experiences with Glioblastoma Multiforme

Our privacy / cookie policy has changed.
Click HERE to read it!